Eutropics Pharmaceuticals
Cambridge
About Eutropics Pharmaceuticals
Eutropics Pharmaceuticals is a team of skilled scientists and project managers that drive LDT and IVD testing from inception through clinical trials. Eutropics investigates apoptosis and immunological signaling networks to find functional biomarkers. The capacity of Eutropics to build unique biomarker assays that profile peripheral blood or bone marrow biopsies has been shown to be useful in AML, CLL, MM, ALL, DLBCL, MDS, and other heme-malignancies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $800.0K
- Funding stage: Seed
- Last round: Grant (Jun 2019)
- Website: eutropics.com
- Phone: +1 6173146431
Industries & Categories
Health Care, Oncology, Personal Health, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/eutropics-pharmaceuticals-165815 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.